Skip to content

Euticals

Pharma·Italy·Exited 2016·Held 4yr
Entry
2012
Hold
4yr
Exit
2016

Who owns Euticals?

Euticals was owned by Clessidra Private Equity SGR through Clessidra Capital Partners II (2009 vintage) from 2012 to 2016, exited via Trade Sale. Across its history, Euticals has been through 3 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-19

Clessidra Private Equity SGR
Most recent investor
Clessidra Private Equity SGR
Clessidra Capital Partners II · 2009 · Buyout
3 ownership periods · full history below

Key facts

HQItaly
SectorPharma
StatusAcquired
Key takeaways
  • ·Fully exited in 2016.
  • ·Average hold across 3 realized cycles: 4 years.

Ownership history

3 ownership periods · co-invest detected

Exited
Last exited in 2016 to .
Mindful Capital Partners
2008 · 2012(4yr) · Mandarin Capital Partners I · 2007 · Buyout
Secondary · to
MOIC
Co-invest · 2 holders · 2012 · 2016
Private Equity Partners
2012 · 2016(4yr) · Private Equity Partners Fund IV · 2007 · Buyout
Trade Sale · to
MOIC
Clessidra Private Equity SGR
2012 · 2016(4yr) · Clessidra Capital Partners II · 2009 · Buyout
Trade Sale · to
MOIC
Track Euticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Euticals?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Euticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue